CN103908490A - Pure plant traditional Chinese medicinal preparation for treating myocardial infarction and cardiovascular diseases and preparation method thereof - Google Patents
Pure plant traditional Chinese medicinal preparation for treating myocardial infarction and cardiovascular diseases and preparation method thereof Download PDFInfo
- Publication number
- CN103908490A CN103908490A CN201410118682.6A CN201410118682A CN103908490A CN 103908490 A CN103908490 A CN 103908490A CN 201410118682 A CN201410118682 A CN 201410118682A CN 103908490 A CN103908490 A CN 103908490A
- Authority
- CN
- China
- Prior art keywords
- preparation
- radix
- myocardial infarction
- cardiovascular disease
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a pure plant traditional Chinese medicinal preparation for treating myocardial infarction and cardiovascular diseases and a preparation method thereof. The preparation comprises the following traditional Chinese medicinal components by weight: 6-15g of codonopsis pilosula, 6-15g of astragalus membranaceus, 6-15 parts of ligusticum wallichii, 8-15g of liquorice, 8-15g of pseudo-ginseng and 50-150ml of gingko leaf extract. The preparation method comprises the following steps: quenching the traditional Chinese medicinal materials for about 4 hours according to the requirement on dosage and quantity; uniformly stirring, adding the gingko leaf extract, and mixing; pouring the mixture in a traditional Chinese medicament extraction bag, putting the bag in a high-pressure kettle, and gradually heating to 105-115 DEG C; cooling to 100 DEG C in the high-pressure kettle, sealing and filling the liquid medicine into a finished product with 50-100ml in each bag to obtain the solution preparation; and storing at normal temperature. The pure plant traditional Chinese medicinal preparation can be used for improving micro-circulation of a human body, eliminating oxygen radicals, remarkably increasing the heart coronary blood flow, remarkably promoting brain blood circulation, increasing brain blood flow rate and regulating blood fat, so that the blood viscosity can be reduced, blood circulation can be improved, and the aging process of a human body can be delayed. The pure plant traditional Chinese medicinal preparation adopts pure plant traditional Chinese medicinal materials, is restrict in formula, mild in action, low in cost and small in dosage, gradually plays drug effects, and does hurt the liver or kidney of a patient.
Description
Technical field
The present invention relates to a kind of pure botanical herbs preparation and preparation method for the treatment of myocardial infarction and cardiovascular disease, belong to pure Chinese drug preparation technique field.
Background technology
Cardiovascular disease is current global modal chronic disease.According to investigations, China's cardiovascular patient number has exceeded 2.7 hundred million at present, calculates by national population 1,400,000,000, in nearly 10 Chinese, just has 2 people to suffer from cardiovascular disease.Die from every year cardiovascular diseases's patient approximately 3,000,000 people.Almost in every dead 10 people, just having 2 people is cardiovascular disease, average cardiovascular death 340 people per hour.More it is disturbing, according to the trend prediction of cardiovascular diseases's statistical data, to the year two thousand twenty, China will be every year because the number of cardiovascular disease death may reach 4,000,000.By 3-5 ten thousand yuan of calculating of everyone medical expense, only this item disease, probable cost 1,500 hundred million-2,000 hundred million, add the medical expense that other cardiovascular patients are usual, more up to 4000-5,000 hundred million yuan, seriously drag the back leg of national economy every year, hindered the development of national economy.Cardiovascular disease has become the first cause of the death of China's city and country population, and myocardial infarction is again the noninfectious that the rate of causing death is the highest.Male is higher than women for cardiovascular death rate, and mortality rate gathers way rural area higher than city.Cardiovascular diseases becomes younger, aging and rural area trend obvious.Approximately there are every year 8000000 needs of patients to accept operation on heart, according to statistics only 170,000 example left and right of national cardiac operation total amount in 2010.In cardiac operation, congenital heart disease ranks first (60%-65%), and valvular heart disease takes second place (20%-25%), outer 3 of the grade the candidates in the imperial examinations (10%-20%) of coronary heart disease.China's Incidence of CHD 4.6%, year amount for surgical is only in 3 ten thousand-5 ten thousand people left and right, and 98% patient does not obtain the effective treatment.Cardiothoracic surgery Wang of Nanjing No.1 Hospital rises in the academic meeting of the international cardiovascular diseases of the 14 southern china holding April 11 2012 dawn, and the severe situation of Prevention of cardiovascular disease becomes participant authoritative expert's common recognition.Everybody proposes, preventing and treating cardiovascular disease only in the face of clinical be inadequate, prevent even more important, proposal promote medical science transform the Second Revolution." the 2012 world health statistical report " announced according to World Health Organization (WHO), morbidity and the mortality rate of China's cardiovascular disease (heart disease, apoplexy) are lasting ascent stage always, and acute coronary syndrome (being the general designation to diseases such as unstable angina, acute myocardial infarction, sudden cardiac death, malignant arrhythmias) is 50/100000ths left and right at Chinese sickness rate.If can not get timely rescue after morbidity, mortality rate is high.Once after cardiovascular disease morbidity, illustrate that the organic disease of heart forms, doctor trained in Western medicine surgical operation, in the time of the life of rescue patient, is very effective and necessary.Although the treatment of domestic operation on heart has approached or reached international standards, complicated surgical intervention quality and quantity is also undesirable; , also there is larger difference in the effect of domestic treatment means including coronary heart disease intervention and bypass surgery, radio-frequency (RF) ablation and Pacemaker implantation; Lack the diagnostic techniques path of unified and specification; 98% heart disease at final stage patient, does not obtain timely and effective treatment.Only depend on the clinical rescue of doctor trained in Western medicine and operation, the prognosis of cardiovascular patient, unsatisfactory, can't resolve treatment and the rehabilitation problem of China's cardiovascular patient far away.After that operation, think that cardiovascular disease eradicates, by the treatment of some months, the idea that just can fully recover is harmful to very much.Facts have proved, after 5-10 years, most patients, disease has the trend increasing the weight of on the contrary.Quite a few is dead because the later stage has loosened treatment.So-called ' fall ill and fall as mountain, cure the disease as reeled off raw silk from cocoons ' is exactly this reason.Therefore the treatment of noninfectious, only controls, changes original life and treatment pattern ' being the Second Revolution that advocated promotion medical science transforms ' from source, could fundamentally prevent the generation of cardiovascular disease.Noninfectious has become global crisis at present, and various countries reach common understanding, and developing country " severely afflicated area " especially.In JIUYUE, 2011, Secretary-General of the United Nations Ban Ki-moon points out in the 66th United Nations General Assembly's prevention and the high-level meeting of control noninfectious: in every 10 people in the whole world, just have 2 people to die from the noninfectious including diabetes, cardiovascular and cerebrovascular disease, chronic obstructive pulmonary disease and cancer; The positive major raid of noninfectious developing country; But developing country is also not ready for; Have and exceed 1/4 people who dies from this noninfectious also in the prime of life; These people's major parts are in developing country.At present, cardiovascular disease is that noninfectious mortality rate is the highest.The People's Hospital of Peking University's heart grinds chief professor Hu great Yi of institute and says, China's Prevention of cardiovascular disease present situation presents " four high four low " feature: i.e. high incidence, high mortality, high relapse rate, high medical expense; Low awareness, low treatment rate, low compliance rate, prophylactic agent utilization rate are low.In high medical expense, Operation Fee, salvage have accounted for 50%-65%.Form and there is no disease, do not checked; Disease is not heavy, does not take medicine; Go to the hospital, be afraid of to spend; Be not critically ill, the medical vicious circle of not performing the operation.Professor Hu great Yi points out, cardiovascular disease emphasis is anti-but not control.The problem that China's Prevention of cardiovascular disease faces is not technology, is not hardware, is not expense, but system and theory.Aspect Prevention of cardiovascular disease, doctors should establish correct goals of medicine, taking promotion health and prevent disease as own duty." should promote the Second Revolution of medical science, we are the knowledge of health promotion, health education and disease control in the urgent need to study, promote the Second Revolution of medical science.”
And in the medical science Second Revolution, with the method diagnosis of doctor trained in Western medicine, become common recognition with the method treatment of the traditional Chinese medical science.The targeted therapy of doctor trained in Western medicine, as cardiovascular diseases's acute attack stage, rescue and operation are only ways; In recovery and the treatment of cardiovascular stable phase, Chinese medicine is good method.In fact the Second Revolution of medical science be exactly the medical revolution that the traditional Chinese medical science and doctor trained in Western medicine, Chinese medicine and Western medicine, treatment and rehabilitation, operation and exercise, diet and medicine etc. combine.
Summary of the invention
Technical problem to be solved by this invention is: a kind of pure botanical herbs preparation for the treatment of myocardial infarction and cardiovascular disease is provided, and the present invention simultaneously also provides the preparation method of its various preparations
For solving the problems of the technologies described above, the technical solution used in the present invention is:
Treat a pure botanical herbs preparation for myocardial infarction and cardiovascular disease, comprise the Chinese medicinal components of following weight: Radix Codonopsis 6-15g, Radix Astragali 6-15g, Rhizoma Chuanxiong 6-15g, Radix Glycyrrhizae 8-15g, Radix Notoginseng 8-15g and ginkgo biloba succi 50ml-150ml.
Preferably, the weight of above-mentioned each Chinese medicinal components is: Radix Codonopsis, the Radix Astragali, the each 9g of Rhizoma Chuanxiong, Radix Glycyrrhizae, the each 10-15g of Radix Notoginseng, ginkgo biloba succi 50ml-150ml.
Patient is at the dose of first month, and the consumption of preferred each Chinese medicine is: Radix Codonopsis, the Radix Astragali, Rhizoma Chuanxiong 6-15g, Radix Glycyrrhizae 12g; Radix Notoginseng 15g; Ginkgo biloba succi 50ml.
Patient is at the dose of second month, and the consumption of preferred each Chinese medicine is: Radix Codonopsis, the Radix Astragali, Rhizoma Chuanxiong 6-15g, Radix Glycyrrhizae 12g; Radix Notoginseng 15g; Ginkgo biloba succi 75ml.
Patient is at trimestral dose, and the consumption of preferred each Chinese medicine is: Radix Codonopsis, the Radix Astragali, Rhizoma Chuanxiong 6-15g, Radix Glycyrrhizae 12g; Radix Notoginseng 15g; Ginkgo biloba succi 100ml.
Patient was at the dose of four month, and the consumption of preferred each Chinese medicine is: Radix Codonopsis, the Radix Astragali, Rhizoma Chuanxiong 6-15g, Radix Glycyrrhizae 12g; Radix Notoginseng 15g; Ginkgo biloba succi 150ml.
The pure botanical herbs preparation for the treatment of myocardial infarction described above and cardiovascular disease, its dosage form that can prepare is solution, capsule, tablet or drop pill.
The present invention also provides the preparation method of various dosage forms, and the method for pharmaceutical solutions, comprises the following steps:
First various pure botanical herbses are pressed to consumption and capacity requirement, about merceration 4 hours, after stirring, add ginkgo biloba succi, after being mixed, pour in Chinese medicine extraction bag, put into autoclave, heat gradually to 105-115 DEG C, in autoclave, be cooled to after 100 DEG C, medicinal liquid is sealed to the finished product that fill becomes 50-100ml/ to wrap, obtain solution dosage, under room temperature, preserve.
Further, by the medicinal liquid of acquisition 80 spend stir 10 minutes, cooling after, staticly settle natural filtration; Vacuum concentration, to extractum shape, adds pharmaceutical aids, vacuum drying; With capsule, tablet, pill dripping machine filling, obtain capsule, tablet or drop pill.
Acting as of the various Chinese herbal medicine that the present invention relates to:
The effect of Radix Codonopsis and effect: QI invigorating is double to nourish blood, QI and blood deficiency, the cardiopalmus of breathing hard, lassitude and weak; Can make erythrocytosis, hemoglobin increase.
The effect of the Radix Astragali and effect: blood vessel dilating, reduction blood viscosity, minimizing thrombosis; Reduce blood pressure; Cardioprotection, two-ways regulation blood glucose, free radical resisting damage; Defying age, anti-hypoxia, antitumor, the effect of enhancing human body immunity power.Can be used to treat the diseases such as heart, hypertension, diabetes.
Effect of Rhizoma Chuanxiong and effect: blood-activating and qi-promoting, wind-expelling pain-stopping.
The effect of Radix Glycyrrhizae and effect: separate hundred poison.Property flat, taste flat, GUIXIN, lung, spleen.The function of coordinating the actions of various ingredients in a prescription have invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, and can cushion toxicity, strong.Be the famous large Chinese medicine material of China, applicating history is long, famous at home and abroad.
The effect of Radix Notoginseng and effect: blood circulation promoting and blood stasis dispelling, blood fat reducing and blood pressure, increase coronary flow, improve microcirculation.For angina pectoris.
The effect of Folium Ginkgo and effect: the effects such as the useful heart is astringed the lung, removing dampness antidiarrheal." Chinese medicinal herbal " records it can " gas of astringing the lung, relievings asthma and coughs, and leukorrhagia stopping is turbid ".According to modern pharmacological research, can improve cardiovascular and peripheral vessels circulatory function, myocardial ischemia is improved to effect, there is the effect that promotes memory, improves brain function.In addition, can also reduce blood viscosity, remove free radical.
Mechanism of action of the present invention is: Folium Ginkgo is monarch drug (principal agent), by antagonism platelet activating factor, regulates blood fat (to reduce T-CHOL, triglyceride and low density lipoprotein, LDL; High density lipoprotein increasing) and improve microcirculation, (obviously improve microvascular velocity of blood flow, obviously improve microvascular fluidised form extremely, obviously improve microvascular loop top congestion) solved erythrocytic band oxygen amount and penetrated and degeneration ability; Fundamentally improve cardiac's the state of an illness and prognosis.Solve the problem such as blood supply insufficiency and valvular regurgitation, thereby solved the root of Angina, played the effect consolidating.And the Chinese medicines such as Radix Codonopsis, the Radix Astragali, Rhizoma Chuanxiong, Radix Glycyrrhizae, Radix Notoginseng are ministerial drug (from medicines) in prescription.Play: benefiting qi and nourishing blood, QI and blood deficiency, the cardiopalmus of breathing hard, blood vessel dilating, reduction blood viscosity; Reduce thrombosis; Reduce blood pressure; Cardioprotection, two-ways regulation blood pressure and blood glucose; Free radical resisting damage; Defying age, anti-hypoxia, antitumor, the effect of enhancing human body immunity power.Enrich blood and invigorate blood circulation; Circulation of qi promoting blood stasis dispelling, loosening bowel to relieve constipation, increases the diseases such as coronary flow.
The main mechanism of the present invention is as follows:
At present medical circle, in the time of Cardiovarscular, adopts targeted therapy principle mostly, and heart is performed the operation or the single method treatment such as coronary dilating, penetrating, thrombolytic, and this acute attack stage in cardiovascular disease is necessary and necessity; But be only nowhere near like this.Because these simple treatments, can not fundamentally regulate blood fat and improve patient's microcirculation; Can not thoroughly repair the position of heart damage; Do not become lesion vessels collateral circulation around, just can't resolve the root problem of myocardial ischemia and ischemia oxygen yet; Can't resolve again erythrocytic nutriment and the low problem of blood oxygen amount of carrying; More can't resolve the problem that erythrocytic degeneration and penetration capacity decline.To the complication causing due to hypertension and diabetes, there is no effect at all.Like this, even if for the moment alleviated the state of an illness, eliminate danger, but As time goes on (3-5 years), patient's the cardiovascular state of an illness, can only be more and more heavier, had a strong impact on patient's quality of life, and what have even meets accident.The main cause of the generation of cardiovascular accident is arteriosclerosis, and arteriosclerosis, easily occurs in the blood vessel at the each position of whole body; The most easily occurring arteriosclerotic is heart coronary artery and brain; The arterial wall of the heart, brain will thicken year by year, and blood vessel elasticity reduces, tube wall becomes crisp hard; And the formation of the heart, cerebrovascular generation microcirculation disturbance and speckle; Further develop and can make cardiovascular tube chamber narrow gradually, cause heart ischemia, cause coronary heart disease and various malfunction; Form thrombosis, even blood vessel entirely shuts, and causes myocardial infarction.Therefore protect vascular endothelial cell to exempt from damage, reduction blood fat and the capillary fragility of oxygen-derived free radicals, platelet activating factor; improve hyperlipemia patient's microcirculation and reduce blood viscosity; thereby preventing from reducing arteriosclerotic incidence rate and recover blood vessel elasticity, is very important.Pure botanical herbs preparation of the present invention contains these active ingredients: have and remove oxygen-derived free radicals, reduce cholesterol, reduce the effect of capillary fragility and stronger antagonism platelet activating factor.The cholesterol that not only shows to have reduction and can bring out the heart, cerebral arteriosclerosis, can also improve the high density lipoprotein useful to the mankind.The particularly important is can improve microcirculation blood flow abnormal, improve blood capillary velocity of blood flow and improve whole blood specific viscosity.The description of " same longevity of arteries and human life " this syntax state well-known doctor's medical science maxim image the mankind's good health and a long life, and relation between the heart, cerebrovascular.Modern antidotal studies confirm that by the microcirculatory adjusting of the mankind, particularly start with and can significantly improve human heart and cerebrum blood supply from the microcirculation of heart and brain, delay the arteriosclerosis of human heart and brain, prompting people are by strengthening the heart, cerebrovascular unimpeded, thereby are the health that ensures the mankind, the aging course that delays the mankind extends the mankind's the important step in life-span.
Pure botanical herbs preparation of the present invention has following pharmacological action:
1, can improve the microcirculation of human body: the particularly important is by the hematoblastic cohesion of antagonism and improve microcirculation.Can improve microcirculation blood flow abnormal, improve blood capillary velocity of blood flow and improve whole blood specific viscosity.Because microcirculation disturbance is mankind aging's principal character, be the main cause that causes the heart, cerebrovascular disease, therefore for delaying mankind aging, prevention and the treatment heart, cerebrovascular disease are particular importances.
2, can eliminate oxygen-derived free radicals: can suppress the metabolites harmful to blood vessel such as lipid peroxide, thereby reduce the infringement of these materials to blood vessel.
3, can obviously increase heart coronary artery blood flow: improve the nutriture of heart, there is prevention and treatment deficiency myocardial blood supply, promote the blood circulation of heart and the effect of metabolic function.
4, can obviously promote brain blood circulation and increase cerebral blood flow: thus memory reinforcing, improve insomnia, prevention and treatment cerebral arteriosclerosis and apoplexy, delay the decline of brain function.
5, regulate blood fat: comprise and reduce serum total cholesterol, triglyceride and low density lipoprotein, LDL; Increase high density lipoprotein, reduce the viscosity of blood, improve blood circulation, thereby delay the mankind's aging course.
6, can reduce erythrocytic gathering, improve hemorheological property: thus the blood flow of the whole body blood vessel including heart coronary artery and cerebral arteries improved.
7, can improve erythrocytic band oxygen amount, degeneration and penetration capacity: the permeability that reduces blood capillary.And keep the elasticity of blood vessel.
8, improve the mitochondrial breathing rate of brain cell: increase the synthetic of ATP, improve the metabolism of brain cell.
The present invention is through Chinese People's Liberation Army Qingdao 401 hospitals and the clinical verification of the Shandong hospitals of traditional Chinese and western medicine, and therapeutic effect is obvious, and aobvious rate is up to 95%.Through Yantai and the outpatient service of two places, Qingdao, take through several thousand routine patients, evident in efficacy, cure rate is up to more than 98%.
Detailed description of the invention
embodiment 1
Treat a pure botanical herbs preparation for myocardial infarction and cardiovascular disease, comprise the Chinese medicinal components of following weight: Radix Codonopsis, the Radix Astragali, the each 9g of Rhizoma Chuanxiong, Radix Glycyrrhizae, the each 15g of Radix Notoginseng, ginkgo biloba succi 50ml-150ml.
Preparation method comprises the following steps:
First various pure botanical herbses are pressed to consumption and capacity requirement, about merceration 4 hours, after stirring, add ginkgo biloba succi, after being mixed, pour in Chinese medicine extraction bag, put into autoclave, heat gradually to 105 DEG C, in autoclave, be cooled to after 100 DEG C, medicinal liquid is sealed to the finished product that fill becomes 50ml/ to wrap, obtain solution dosage, under room temperature, preserve.
Further, by the medicinal liquid of acquisition 80 spend stir 10 minutes, cooling after, staticly settle 12 hours, with four layers of gauze and the thick absorbent cotton natural filtration of 1.5cm; Vacuum concentration, to extractum shape, adds pharmaceutical aids, vacuum drying; With capsule, tablet, pill dripping machine filling, obtain capsule, tablet or drop pill.
embodiment 2
Treat a pure botanical herbs preparation for myocardial infarction and cardiovascular disease, comprise the Chinese medicinal components of following weight: Radix Codonopsis, the Radix Astragali, Rhizoma Chuanxiong, Radix Glycyrrhizae 12g; Radix Notoginseng 15g; Ginkgo biloba succi 50ml-150ml.
Preparation method comprises the following steps:
First various pure botanical herbses are pressed to consumption and capacity requirement, about merceration 4 hours, after stirring, add ginkgo biloba succi, after being mixed, pour in Chinese medicine extraction bag, put into autoclave, heat gradually to 105-115 DEG C, in autoclave, be cooled to after 100 DEG C, medicinal liquid is sealed to the finished product that fill becomes 50-100ml/ to wrap, obtain solution dosage, under room temperature, preserve.
Further, by the medicinal liquid of acquisition 80 spend stir 10 minutes, cooling after, staticly settle natural filtration; Vacuum concentration, to extractum shape, adds pharmaceutical aids, vacuum drying; With capsule, tablet, pill dripping machine filling, obtain capsule, tablet or drop pill.
embodiment 3 applies treatment case of the present invention
One, in so-and-so, man, 83 years old, cadre's sanitarium, Xinjiang, Zhifu District, Shandong Yantai City, before 2003, because heart infarction is in hospital twice, chest distress, arrhythmia, cardiac blood supply deficiency, limitation of activity.Take the present invention after two months from May, 2003, symptom takes a turn for the better, without chest distress.Take further consultation after a year, normal ECG, without other discomfort, extremity are strong.Take after a year and a half, can out on tours, upper Qinghai-Tibet Platean, need not be with oxygen cylinder.Heart disease is not violated so far.Indicate to take all the life.
Two, Yang, female, 67 years old, stretching South Street, Zhifu District, Shandong Yantai City, was diagnosed as mitral reflux in 2008, dysraphism, T ripple is inverted, blood supply insufficiency, angina pectoris.Start to take the present invention in August, 2008, December patient blood supply insufficiency symptom is obviously improved.Health check-up in August, 2009, normal ECG.Heart is so far without uncomfortable sensation.Indicate to take all the life.
Three, Feng so-and-so, man, 81 years old, Fu Lai garden, Zhifu District, Shandong Yantai City, was diagnosed as heart infarction in 2000, blood supply insufficiency, twice be in hospital rescue, need to carry emergency cardiac care medicine.After 2000, start to take the product such as bathypelagic fish oil and lecithin of the U.S., effect is general, can not walk and orthobiosis.2003 start to take medicine of the present invention, and after half a year, symptom is improved, and again have an electro-cardiogram and show old heart infarction, without blood supply insufficiency.Take after a year and a half, can be movable by bike.Take after 3 years, the U.S. that goes by aeroplane is on home leave, and there is no uncomfortable reaction.So far angina pectoris commits excesses never again.Indicate to take all the life.
Claims (9)
1. treat the pure botanical herbs preparation of myocardial infarction and cardiovascular disease for one kind, it is characterized in that, comprise the Chinese medicinal components of following weight: Radix Codonopsis 6-15g, Radix Astragali 6-15g, Rhizoma Chuanxiong 6-15g, Radix Glycyrrhizae 8-15g, Radix Notoginseng 8-15g and ginkgo biloba succi 50ml-150ml.
2. the pure botanical herbs preparation for the treatment of myocardial infarction according to claim 1 and cardiovascular disease, is characterized in that, the weight of each Chinese medicinal components is: Radix Codonopsis, the Radix Astragali, the each 9g of Rhizoma Chuanxiong, Radix Glycyrrhizae, Radix Notoginseng 15g, ginkgo biloba succi 50ml-150ml.
3. the pure botanical herbs preparation for the treatment of myocardial infarction according to claim 2 and cardiovascular disease, is characterized in that, Radix Codonopsis, the Radix Astragali, Rhizoma Chuanxiong, Radix Glycyrrhizae 12g; Radix Notoginseng 15g; Ginkgo biloba succi 50ml.
4. the pure botanical herbs preparation for the treatment of myocardial infarction according to claim 2 and cardiovascular disease, is characterized in that, Radix Codonopsis, the Radix Astragali, Rhizoma Chuanxiong, Radix Glycyrrhizae 12g; Radix Notoginseng 15g; Ginkgo biloba succi 75ml.
5. the pure botanical herbs preparation for the treatment of myocardial infarction according to claim 2 and cardiovascular disease, is characterized in that, Radix Codonopsis, the Radix Astragali, Rhizoma Chuanxiong, Radix Glycyrrhizae 12g; Radix Notoginseng 15g; Ginkgo biloba succi 100ml.
6. the pure botanical herbs preparation for the treatment of myocardial infarction according to claim 2 and cardiovascular disease, is characterized in that, Radix Codonopsis, the Radix Astragali, Rhizoma Chuanxiong, Radix Glycyrrhizae 12g; Radix Notoginseng 15g; Ginkgo biloba succi 150ml.
7. the pure botanical herbs preparation of the treatment myocardial infarction described in above-mentioned any one claim and cardiovascular disease, its dosage form is solution, capsule, tablet or drop pill.
8. the method for the pure botanical herbs preparation of the treatment myocardial infarction described in preparation claim 1-6 any one and cardiovascular disease, is characterized in that, comprises the following steps:
First various Chinese medicine is pressed to consumption and capacity requirement, merceration 4 hours, after stirring, adds ginkgo biloba succi, after being mixed, pour in Chinese medicine extraction bag, put into autoclave, heat gradually to 105-115 DEG C, in autoclave, be cooled to after 100 DEG C, medicinal liquid is sealed to the finished product that fill becomes 50-100ml/ to wrap, obtain solution dosage, under room temperature, preserve.
9. the method for the pure botanical herbs preparation of preparation according to claim 8 treatment myocardial infarction and cardiovascular disease, is characterized in that, the medicinal liquid of acquisition 80 is spent and stirred 10 minutes, cooling after, staticly settle natural filtration; Vacuum concentration, to extractum shape, adds pharmaceutical aids, vacuum drying; With capsule, tablet, pill dripping machine filling.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410118682.6A CN103908490A (en) | 2014-03-27 | 2014-03-27 | Pure plant traditional Chinese medicinal preparation for treating myocardial infarction and cardiovascular diseases and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410118682.6A CN103908490A (en) | 2014-03-27 | 2014-03-27 | Pure plant traditional Chinese medicinal preparation for treating myocardial infarction and cardiovascular diseases and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103908490A true CN103908490A (en) | 2014-07-09 |
Family
ID=51034694
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410118682.6A Pending CN103908490A (en) | 2014-03-27 | 2014-03-27 | Pure plant traditional Chinese medicinal preparation for treating myocardial infarction and cardiovascular diseases and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103908490A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104189288A (en) * | 2014-09-16 | 2014-12-10 | 陈远征 | Traditional Chinese medicine composition for treating myocardial infarction and application of traditional Chinese medicine composition |
| CN104922217A (en) * | 2015-06-24 | 2015-09-23 | 广东三才石岐制药股份有限公司 | Heart tonifying and meridian dredging product and preparation method thereof |
| CN106344648A (en) * | 2016-09-26 | 2017-01-25 | 折改梅 | Thymus plant extract and application thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1730021A (en) * | 2005-08-10 | 2006-02-08 | 浙江南洋药业有限公司 | Medicine composition for treating cardiovascular and cerebrovascular diseases and preparing process thereof |
| CN103083400A (en) * | 2013-03-01 | 2013-05-08 | 云南郡筹制药有限公司 | Drug for treating cardiovascular disease |
-
2014
- 2014-03-27 CN CN201410118682.6A patent/CN103908490A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1730021A (en) * | 2005-08-10 | 2006-02-08 | 浙江南洋药业有限公司 | Medicine composition for treating cardiovascular and cerebrovascular diseases and preparing process thereof |
| CN103083400A (en) * | 2013-03-01 | 2013-05-08 | 云南郡筹制药有限公司 | Drug for treating cardiovascular disease |
Non-Patent Citations (1)
| Title |
|---|
| 李岩等: "补气药党参黄芪对慢性心衰大鼠血流动力学的影响", 《中国中医基础医学杂志》 * |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104189288A (en) * | 2014-09-16 | 2014-12-10 | 陈远征 | Traditional Chinese medicine composition for treating myocardial infarction and application of traditional Chinese medicine composition |
| CN104189288B (en) * | 2014-09-16 | 2017-10-27 | 张玉清 | A kind of Chinese medicine composition for treating myocardial infarction and its application |
| CN104922217A (en) * | 2015-06-24 | 2015-09-23 | 广东三才石岐制药股份有限公司 | Heart tonifying and meridian dredging product and preparation method thereof |
| CN104922217B (en) * | 2015-06-24 | 2017-11-03 | 三才石岐制药股份有限公司 | A kind of bushing is promoted blood circulation product and preparation method thereof |
| CN106344648A (en) * | 2016-09-26 | 2017-01-25 | 折改梅 | Thymus plant extract and application thereof |
| CN106344648B (en) * | 2016-09-26 | 2020-09-04 | 折改梅 | Thymus plant, extract and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104013849A (en) | Traditional Chinese medicinal composition for treating hypertension and preparation method thereof | |
| CN103202879B (en) | Traditional Chinese medicine composition for treating chronic cardiac failure and preparation method thereof | |
| CN101095768B (en) | Chinese traditional medicine capsule for treating primary hypertension for persons in middle and old age | |
| CN102210835B (en) | Traditional Chinese medicine for treating coronary disease | |
| CN104758353B (en) | A kind of pharmaceutical composition and its preparation method and application for treating angiocardiopathy | |
| CN103908490A (en) | Pure plant traditional Chinese medicinal preparation for treating myocardial infarction and cardiovascular diseases and preparation method thereof | |
| CN103610936B (en) | A kind of Chinese medicine preparation and preparation method for the treatment of coronary heart disease | |
| CN101843843A (en) | Chinese medicament for treating diabetes | |
| CN105055967B (en) | A kind of complex health care product and preparation method with auxiliary hyperglycemic function | |
| CN106138831A (en) | A kind of Chinese medicine composition treating cardiovascular and cerebrovascular disease and preparation method thereof | |
| CN102343049A (en) | Chinese medicinal capsules for treating hypertension due to liver-yang hyperactivity | |
| CN102309561B (en) | Pharmaceutical composition used for preventing and treating urarthritis and hyperuricemia | |
| CN106620253B (en) | Traditional Chinese medicine composition for treating bradyarrhythmia | |
| CN104873685A (en) | Medicine for treating coronary heart disease | |
| CN110882347A (en) | A Chinese medicinal composition for treating cardiovascular diseases | |
| CN103385963A (en) | Chinese medicine preparation for treating angina pectoris caused by coronary heart disease | |
| CN108743885A (en) | A kind of Chinese medicine and preparation method thereof for treating Diabetic Macrovascular Complications | |
| CN108096536A (en) | A kind of Chinese medicine composition for treating hemiplegia | |
| CN108014267A (en) | A kind of liter is immunized, reducing blood lipid, the Chinese medicine composition and preparation method thereof for protecting heart and brain | |
| CN103961603B (en) | Traditional Chinese medicine preparationcapable of reducing blood fat and freeing vessels | |
| CN103055122A (en) | Medicine for preventing restenosis after intracoronary stent implantation and preparation method thereof | |
| CN101797330B (en) | Lipid regulating and meridians activating capsule | |
| CN100594914C (en) | Medicine for curing coronary heart disease | |
| CN103655917B (en) | A kind of Chinese medicine for the treatment of cardiovascular and cerebrovascular disease | |
| CN105708985A (en) | Medicine for dredging cardiovascular system and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140709 |
|
| RJ01 | Rejection of invention patent application after publication |